{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:15:24Z","timestamp":1760300124833},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:p>In several solid tumors, an increased stathmin expression is associated with both poor prognosis and resistance to certain chemotherapy types. However, the data regarding melanocytic lesions are very limited. The goals of our study are as follows: the assessment of stathmin expression in benign and malignant melanocytic lesions, and the significance of its expression for the differential diagnostics between benign and malignant lesions; the analysis of the prognostic significance of stathmin expression in melanoma; and the evaluation of stathmin expression in melanoma and melanoma metastases with respect to possible therapeutic targeting. Immunohistochemical analysis of stathmin expression was done in 323 melanocytic lesions, including 205 primary cutaneous melanomas, 60 melanoma metastases, and 58 melanocytic nevi. Stathmin expression was found in all analyzed groups of melanocytic lesions. Using the H-scoring system, the observed intensity of expression was as follows: melanocytic nevi: 146.1 (mean) and 150 (median); melanomas: 116.7 (mean) and 110 (median); and melanoma metastases: 136.8 (mean) and 140 (median). The stathmin expression was significantly lower in the cohort of primary melanomas when compared with metastases and nevi (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.001). The stathmin expression showed no prognostic significance. The high stathmin expression in melanoma suggests that stathmin might be a promising marker for therapeutic targeting in ongoing clinical trials. Compared with several other solid tumors, stathmin expression in melanoma showed no prognostic significance. The potential use of stathmin expression in differential diagnostics is limited by its common expression, and despite the statistically significant differences between nevi and melanoma, it may not be used in this setting.<\/jats:p>","DOI":"10.1097\/cmr.0000000000000550","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:14:56Z","timestamp":1542154496000},"page":"157-162","source":"Crossref","is-referenced-by-count":5,"title":["Stathmin is a potential therapeutic target but not a prognostic marker in melanoma: an immunohistochemical study of 323 melanocytic lesions"],"prefix":"10.1097","volume":"29","author":[{"given":"Pavel","family":"Dundr","sequence":"first","affiliation":[{"name":"Institute of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karol","family":"Simon","sequence":"additional","affiliation":[{"name":"Institute of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krist\u00fdna","family":"N\u011bmejcov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"B\u00e1rt\u016f","sequence":"additional","affiliation":[{"name":"Institute of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Tich\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romana","family":"Mich\u00e1lkov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radek","family":"Jak\u0161a","sequence":"additional","affiliation":[{"name":"Institute of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"V\u011bckov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ond\u0159ej","family":"Kodet","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, First Faculty of Medicine, Charles University and General University Hospital in Prague"},{"name":"Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230902","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/cas.12417","article-title":"Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma","volume":"105","author":"Watanabe","year":"2014","journal-title":"Cancer Sci"},{"key":"R2-20230902","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0955-0674(01)00289-7","article-title":"The oncoprotein 18\/stathmin family of microtubule destabilizers","volume":"14","author":"Cassimeris","year":"2002","journal-title":"Curr Opin Cell Biol"},{"key":"R3-20230902","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/jso.21870","article-title":"Downregulation of stathmin is involved in malignant phenotype reversion and cell apoptosis in esophageal squamous cell carcinoma","volume":"103","author":"Wang","year":"2011","journal-title":"J Surg Oncol"},{"key":"R4-20230902","first-page":"299","article-title":"Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy","volume":"69","author":"Mistry","year":"2002","journal-title":"Mt Sinai J Med"},{"key":"R5-20230902","doi-asserted-by":"crossref","first-page":"78994","DOI":"10.18632\/oncotarget.12982","article-title":"Overexpression of stathmin promotes metastasis and growth of malignant solid tumors: a systemic review and meta-analysis","volume":"7","author":"Biaoxue","year":"2016","journal-title":"Oncotarget"},{"key":"R6-20230902","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/onc.2012.141","article-title":"Stathmin 1 is a potential novel oncogene in melanoma","volume":"32","author":"Chen","year":"2013","journal-title":"Oncogene"},{"key":"R7-20230902","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","article-title":"Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis","volume":"21","author":"Hirsch","year":"2003","journal-title":"J Clin Oncol"},{"key":"R8-20230902","first-page":"100","article-title":"Stathmin expression is a feature of proliferating cells of most, if not all, cell lineages","volume":"72","author":"Rowlands","year":"1995","journal-title":"Lab Invest"},{"key":"R9-20230902","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0888-7543(03)00031-4","article-title":"Expression of stathmin family genes in human tissues: non-neural-restricted expression for SCLIP","volume":"81","author":"Bieche","year":"2003","journal-title":"Genomics"},{"key":"R10-20230902","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1517\/14728222.2011.620951","article-title":"Stathmin: a protein with many tasks. New biomarker and potential target in cancer","volume":"15","author":"Belletti","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"R11-20230902","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1517\/14728222.2012.696101","article-title":"Stathmin 1: a protein with many tasks. New biomarker and potential target in cancer","volume":"16","author":"Nemunaitis","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"R12-20230902","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1586\/14737140.8.9.1461","article-title":"Stathmin 1: a novel therapeutic target for anticancer activity","volume":"8","author":"Rana","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"R13-20230902","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1158\/0008-5472.CAN-10-0545","article-title":"FoxM1 mediates resistance to herceptin and paclitaxel","volume":"70","author":"Carr","year":"2010","journal-title":"Cancer Res"},{"key":"R14-20230902","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.canlet.2008.09.017","article-title":"Down-regulation of stathmin is required for TGF-beta inducible early gene 1 induced growth inhibition of pancreatic cancer cells","volume":"274","author":"Jiang","year":"2009","journal-title":"Cancer Lett"},{"key":"R15-20230902","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/sj.onc.1209864","article-title":"Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53","volume":"26","author":"Alli","year":"2007","journal-title":"Oncogene"},{"key":"R16-20230902","doi-asserted-by":"crossref","first-page":"765","DOI":"10.5483\/BMBRep.2008.41.11.765","article-title":"Regulation of melanocyte apoptosis by Stathmin 1 expression","volume":"41","author":"Zhang","year":"2008","journal-title":"BMB Rep"},{"key":"R17-20230902","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2119\/2007-00046.Wang","article-title":"Inhibiting proliferation and enhancing chemosensitivity to taxanes in osteosarcoma cells by RNA interference-mediated downregulation of stathmin expression","volume":"13","author":"Wang","year":"2007","journal-title":"Mol Med"},{"key":"R18-20230902","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/cgt.2014.74","article-title":"Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxel","volume":"22","author":"Feng","year":"2015","journal-title":"Cancer Gene Ther"},{"key":"R19-20230902","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/dna.2011.1240","article-title":"In vivo safety and antitumor efficacy of bifunctional small hairpin RNAs specific for the human Stathmin 1 oncoprotein","volume":"30","author":"Phadke","year":"2011","journal-title":"DNA Cell Biol"},{"key":"R20-20230902","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/cgt.2010.35","article-title":"Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference","volume":"17","author":"Rao","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"R21-20230902","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/mt.2015.14","article-title":"Phase 1 trial of Bi-shRNA STMN1 BIV in refractory cancer","volume":"23","author":"Barve","year":"2015","journal-title":"Mol Ther"},{"key":"R22-20230902","doi-asserted-by":"crossref","first-page":"e90141","DOI":"10.1371\/journal.pone.0090141","article-title":"Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer","volume":"9","author":"Werner","year":"2014","journal-title":"PLoS One"},{"key":"R23-20230902","first-page":"6502","article-title":"Stathmin is a potential molecular marker and target for the treatment of gastric cancer","volume":"8","author":"Liu","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R24-20230902","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1007\/s13277-015-3361-y","article-title":"Overexpression of stathmin is resistant to paclitaxel treatment in patients with non-small cell lung cancer","volume":"36","author":"Sun","year":"2015","journal-title":"Tumour Biol"},{"key":"R25-20230902","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12967-016-1000-z","article-title":"Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years\u2019 discoveries and developments","volume":"14","author":"Biaoxue","year":"2016","journal-title":"J Transl Med"},{"key":"R26-20230902","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/jgh.12498","article-title":"Stathmin overexpression identifies high risk for lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma patients","volume":"29","author":"Akhtar","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"R27-20230902","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1002\/cncr.27453","article-title":"Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer","volume":"118","author":"Baquero","year":"2012","journal-title":"Cancer"},{"key":"R28-20230902","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1054\/bjoc.1999.0891","article-title":"Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours","volume":"82","author":"Curmi","year":"2000","journal-title":"Br J Cancer"},{"key":"R29-20230902","first-page":"714","article-title":"Stathmin expression in glioma-derived microvascular endothelial cells: a novel therapeutic target","volume":"27","author":"Dong","year":"2012","journal-title":"Oncol Rep"},{"key":"R30-20230902","first-page":"1037","article-title":"Up-regulated expression of stathmin may be associated with hepatocarcinogenesis","volume":"23","author":"Gan","year":"2010","journal-title":"Oncol Rep"},{"key":"R31-20230902","doi-asserted-by":"crossref","first-page":"61742","DOI":"10.18632\/oncotarget.18687","article-title":"Overexpression of stathmin plays a pivotal role in the metastasis of esophageal squamous cell carcinoma","volume":"8","author":"Han","year":"2017","journal-title":"Oncotarget"},{"key":"R32-20230902","first-page":"398","article-title":"Overcoming paclitaxel resistance in lung cancer cells via dual inhibition of stathmin and Bcl-2","volume":"28","author":"Han","year":"2013","journal-title":"Cancer Biother Radiopharm"},{"key":"R33-20230902","doi-asserted-by":"crossref","first-page":"9951","DOI":"10.1007\/s13277-016-4869-5","article-title":"Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma","volume":"37","author":"He","year":"2016","journal-title":"Tumour Biol"},{"key":"R34-20230902","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s13277-013-1345-3","article-title":"Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma","volume":"35","author":"Hsu","year":"2014","journal-title":"Tumour Biol"},{"key":"R35-20230902","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.bjc.6605537","article-title":"Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells","volume":"102","author":"Jeon","year":"2010","journal-title":"Br J Cancer"},{"key":"R36-20230902","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1007\/s13277-013-0882-0","article-title":"Overexpression of stathmin 1 is associated with poor prognosis of patients with gastric cancer","volume":"34","author":"Ke","year":"2013","journal-title":"Tumour Biol"},{"key":"R37-20230902","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bjc.6602991","article-title":"Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis","volume":"94","author":"Kouzu","year":"2006","journal-title":"Br J Cancer"},{"key":"R38-20230902","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.urology.2009.04.088","article-title":"Expression of stathmin in localized upper urinary tract urothelial carcinoma: correlations with prognosis","volume":"74","author":"Lin","year":"2009","journal-title":"Urology"},{"key":"R39-20230902","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/1566524014666140228120913","article-title":"Stathmin, interacting with Nf-kappaB, promotes tumor growth and predicts poor prognosis of pancreatic cancer","volume":"14","author":"Lu","year":"2014","journal-title":"Curr Mol Med"},{"key":"R40-20230902","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/labinvest.2014.124","article-title":"Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer","volume":"95","author":"Nie","year":"2015","journal-title":"Lab Invest"},{"key":"R41-20230902","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.prp.2015.07.009","article-title":"STMN1 overexpression correlates with biological behavior in human cutaneous squamous cell carcinoma","volume":"211","author":"Li","year":"2015","journal-title":"Pathol Res Pract"},{"key":"R42-20230902","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1021\/pr2010956","article-title":"Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker","volume":"11","author":"Tan","year":"2012","journal-title":"J Proteome Res"},{"key":"R43-20230902","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s12253-015-9930-y","article-title":"Elevated STMN1 expression correlates with poor prognosis in patients with pancreatic ductal adenocarcinoma","volume":"21","author":"Li","year":"2015","journal-title":"Pathol Oncol Res"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008390-201904000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T04:01:12Z","timestamp":1693627272000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-201904000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0000000000000550","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}